1. Home > Latest Topics >

Question 11: Therapeutic considerations when treating AECB

20 June, 2018

question_11_6


LATEST TOPICS

Navigating antibiotic resistance in community-acquired pneumonia: Insights from Vietnam
29 October, 2024
Optimising antibiotic therapy: Insights on transitioning from intravenous to oral treatment for community-acquired pneumonia
27 September, 2024
Community-acquired pneumonia in Cambodia: Navigating the growing challenge of AMR
30 June, 2024
Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024

RELATED ARTICLES

The challenge of CA-UTI treatment and the role of fluoroquinolones
26 September, 2022
Observing the Development of Quinolones from the Rational Application of Antibacterial Drugs During the COVID-19 Pandemic
21 March, 2023
Pharmacokinetic and microbial susceptibility studies of sitafloxacin
10 February, 2023
Management of urinary tract infections: An overview
20 December, 2023
Fluoroquinolones for the Management of Skin and Soft Tissue Infections
13 June, 2023